CurrentEndo coverage · page 7 of 33

Cardiovascular Diabetology

Briefs 241–280 of 1,291 CurrentEndo has covered from this journal, newest publication first

Latest from Cardiovascular Diabetology

All coverage, newest first

Cardiovasc Diabetol24 Dec 2025
Cardiovascular outcomes associated with incident diabetes during statin therapy: a nationwide propensity-matched cohort study
Cohort studyT2D & other
Cardiovasc Diabetol24 Dec 2025
Glucagon-like peptide-1 receptor agonists and risk for cardiovascular events in older adults treated with levothyroxine: a target trial emulation
Cohort studyT2D & other
Cardiovasc Diabetol22 Dec 2025
Very long-chain saturated fatty acids in plasma lipids: association with cardiometabolic risk influenced by lipid interactions
Cohort studyT2D & other
Cardiovasc Diabetol20 Dec 2025
Once-weekly semaglutide versus placebo for the treatment of type 2 diabetes and chronic kidney disease in Denmark: A long-term cost-effectiveness analysis based on FLOW
Research articleT2D & other
Cardiovasc Diabetol19 Dec 2025
Association between the cumulative estimated glucose disposal rate and incident stroke in adults aged 50 and above without diabetes: a prospective nationwide cohort study in China
Cohort study
Cardiovasc Diabetol17 Dec 2025
Arterial collagen IV and laminin levels associate with type 2 diabetes, glycemic control, major adverse cardiac events, and mortality in coronary bypass patients
Cohort studyT2D & other
Cardiovasc Diabetol16 Dec 2025
Myocardial interstitial fibrosis and subclinical left ventricular systolic dysfunction in type 2 diabetes mellitus patients with obesity: a 3.0 T MRI study
Cross-sectional studyT2D & other
Cardiovasc Diabetol15 Dec 2025
Additive value of combining triglyceride-glucose index and estimated glucose disposal rate for incident stroke prediction across glycaemic-regulation subgroups: a prospective cohort of 5,789 Chinese adults
Cohort study
Cardiovasc Diabetol14 Dec 2025
Proteomic signature of metabolic dysfunction-associated steatotic liver disease and risk of atherosclerotic cardiovascular disease
Cohort studyLipids & liver
Cardiovasc Diabetol14 Dec 2025
Combined association of triglyceride-glucose index and the atherogenic index of plasma with the incidence of cardiovascular diseases among middle-aged and older population
Cohort studyLipids & liver
Cardiovasc Diabetol13 Dec 2025
Association between triglyceride-glucose index combined with a body shape index and atherosclerotic cardiovascular disease risk varies by glycemic status: insights from the UK Biobank
Cohort studyT2D & other
Cardiovasc Diabetol13 Dec 2025
Association between triglyceride–glucose muscle-loss index (TyG–MLI) and incident cardiovascular disease: a prospective cohort study in the UK biobank
Cohort studyComplications
Cardiovasc Diabetol13 Dec 2025
Cardioprotective mechanism of ω-3 fatty acid icosapent ethyl (IPE) in cardiomyocytes: role in high glucose and shear stress-induced mechano-transduction dysregulation
Mechanistic study
Cardiovasc Diabetol12 Dec 2025
Soluble RAGE further stratifies risk of coronary artery and end-stage kidney disease in high-risk individuals with type 1 diabetes and treatment-resistant hypertension
Cohort studyT1D
Cardiovasc Diabetol11 Dec 2025
Plasma volume status in type 2 diabetes and its association with antidiabetic therapy
Cohort studyT2D & other
Cardiovasc Diabetol11 Dec 2025
C-reactive protein and prospective cardiometabolic risk: observational and Mendelian randomization study of ischemic stroke and all-cause death
Cohort study
Cardiovasc Diabetol10 Dec 2025
Calciprotein crystallization time (T50) and its association with surrogate cardiovascular disease risk markers in individuals with type 2 diabetes mellitus: the cross-sectional EARLY-HFpEF study
Cross-sectional studyT2D & other
Cardiovasc Diabetol10 Dec 2025
Effects of metabolic syndrome and its components on myocardial microcirculation in obstructive coronary artery disease patients: a CMR perfusion study
Cross-sectional study
Cardiovasc Diabetol9 Dec 2025
Proteomics mediates the effects of biological aging on the progression of cardio-renal-metabolic comorbidity: a UK biobank cohort study
Cohort studyT2D & other
Cardiovasc Diabetol8 Dec 2025
Circulating long non-coding RNAs as predictors of type 2 diabetes mellitus development: results from the CORDIOPREV study
Cohort studyT2D & other
Cardiovasc Diabetol8 Dec 2025
Interplay between frailty and cardiometabolic disorders: from pathophysiology to clinical implications
Meta-analysisT2D & other
Cardiovasc Diabetol8 Dec 2025
Comprehensive CMR evaluation including 4D flow-derived E/A vorticity ratio in overweight adults with and without type 2 diabetes mellitus
Cross-sectional studyT2D & other
Cardiovasc Diabetol7 Dec 2025
Stress hyperglycemia ratio and physical frailty in HFpEF
Cohort study
Cardiovasc Diabetol5 Dec 2025
Effects of finerenone on arterial stiffness and cardiorenal biomarkers in patients with type 2 diabetes and chronic kidney disease: a randomised placebo-controlled mechanistic trial (FIVE-STAR)
Randomized controlled trialT2D & other
Cardiovasc Diabetol2 Dec 2025
Prognostic implications of quantified coronary atherosclerosis and myocardial perfusion in diabetes
Cohort studyT2D & other
Cardiovasc Diabetol2 Dec 2025
Data-driven phenotypic profiling of prediabetes reveals heterogeneous cardiometabolic risks in Chinese adults
Cohort studyT2D & other
Cardiovasc Diabetol1 Dec 2025
Impact of type 2 diabetes on the relationship between chronic kidney disease and cardiovascular outcomes in heart failure across ejection fraction: observational study from the Swedish heart failure and the Swedish National diabetes registries
Cohort studyT2D & other
Cardiovasc Diabetol1 Dec 2025
The atherogenic index of plasma predicts long-term outcomes in patients with severe coronary artery calcification undergoing rotational atherectomy: a machine learning-based cohort study
Cohort study
Cardiovasc Diabetol28 Nov 2025
Joint association of urinary albumin-to-creatinine ratio within normal range and triglyceride-glucose index with incident cardiovascular disease: a prospective cohort study
Cohort study
Cardiovasc Diabetol27 Nov 2025
Plasma inflammatory proteome profiles identify MASLD among children with overweight or obesity
Diagnostic or prognostic studyObesity
Cardiovasc Diabetol26 Nov 2025
Neutrophil cathepsin G and risk of cardiovascular events in patients with diabetes mellitus
Cohort studyT2D & other
Cardiovasc Diabetol26 Nov 2025
Interplay among lipoprotein(a), hepatic and vascular damage in individuals with metabolic dysfunction
Cohort studyLipids & liver
Cardiovasc Diabetol24 Nov 2025
Body mass index (BMI) associates with frequency of arterial hypertension and type 2 diabetes in obese patients candidates for bariatric surgery
Cross-sectional studyObesity
Cardiovasc Diabetol24 Nov 2025
Temporal and subgroup disparities in mediation effects on cardiovascular outcomes with liraglutide and semaglutide: a post-hoc analysis of LEADER and SUSTAIN-6 trials
Secondary analysisT2D & other
Cardiovasc Diabetol21 Nov 2025
Association between the atherogenic index of plasma and major adverse cardiovascular events in individuals with metabolic syndrome: findings from the UK biobank
Cohort studyLipids & liver
Cardiovasc Diabetol21 Nov 2025
Diabetes modifies the association between the triglyceride-glucose index and subclinical myocardial injury: A prospective cohort study
Cohort studyT2D & other
Cardiovasc Diabetol21 Nov 2025
Comparable performance of 1,5-anhydroglucitol and continuous glucose monitoring in detecting subclinical atherosclerosis in elderly patients with type 2 diabetes
Cross-sectional studyT2D & other
Cardiovasc Diabetol19 Nov 2025
Plasma metabolomics disentangles T2DM- and CAD-specific dysmetabolism and identifies potential biomarkers for CAD risk escalation in diabetic patients
Cross-sectional studyT2D & other
Cardiovasc Diabetol19 Nov 2025
Elevated triglyceride-glucose index and risk of thymoma-associated myasthenia gravis: a prospective analysis from the UK Biobank
Cohort studyEndocrine cancer
Cardiovasc Diabetol19 Nov 2025
Risk of all–cause death and pancreatic events following GLP-1 RA initiation in people with obesity or type 2 diabetes: observations from a federated research network
Cohort studyT2D & other

All 1,291 Briefs in ExploreShowing Briefs 241–280 of 1,291, newest first